Medications used among Non-Hospitalized Pregnant Women with COVID-19: a Prospective Individual Patient Data Meta-analysis in Europe and North America
de Bruin, O.; Maisonneuve, E.; Hurley, E.; Nordeng, H. M. E.; Berard, A.; Sheehy, O.; Kaul, P.; Shinde, M. U.; Cosgrove, A.; Lyons, J. G.; Messenger-Jones, E.; Kempner, M. E.; Toh, S.; Hua, W.; Hernandez-Munoz, J. J.; Sahin, L.; Cesta, C. E.; Hagg, D.; Gini, R.; Paoletti, O.; Poblador-Plou, B.; Jordan, S.; Thayer, D.; Rodriguez-Bernal, C. L.; Sanchez-Saez, F.; Lassalle, R.; Bernard, M.-A.; Alsina, E.; Ahmadizar, F.; Favre, G.; Panchaud, A.; Bloemenkamp, K. W. M.; Plueschke, K.; de Vries, C.; Siiskonen, S. J.; Sturkenboom, M. C. J. M.; on behalf of the CONSIGN collaboration group,
Show abstract
AimTo estimate the prevalence of medication use in non-hospitalized pregnant women with COVID-19 MethodsA prospective two-stage individual patient meta-analysis across 10 data sources in Europe and North America studied medication use among non-hospitalized pregnant women with COVID-19 between January 2020 to December 2022. Comparisons were made between medication use within 30 days pre- and post-COVID-19 diagnosis in this cohort and two comparator groups: pregnant women without COVID-19, and non-pregnant women with COVID-19. Prevalence estimates were pooled using a random-effects model stratified by trimester. Results50,335 non-hospitalized pregnant women with COVID-19 were identified. The pooled prevalence of antibacterial use in 3rd trimester was higher post-COVID-19 diagnosis (6.8%, 95%CI 5.5-8.4, I2=94%) compared with the same women pre-COVID-19 (3.9%, 95%CI 3.1-4.9, I2=89%). Overall, pregnant women with COVID-19 had higher medication use compared to pregnant women without COVID-19, although these differences were not statistically significant. Post-COVID-19, antithrombotics prevalence was 4.5% (95%CI 1.1-16.5, I2=100%) among pregnant women with COVID-19 in 3rd trimester, compared to 2.1% (95%CI 1.2-3.6, I2=99%) among those without COVID-19 in 3rd trimester. Compared to non-pregnant women with COVID-19, pregnant women with COVID-19 were less likely to be prescribed analgesics, antiprotozoals, corticosteroids, psychoanaleptics and psycholeptics, and more likely to be prescribed antithrombotics, cough and cold and nasal preparations across all trimesters. High heterogeneity existed in nearly all analyses. ConclusionThis international meta-analysis reveals low medication use and country-specific variations, enhancing insight into the management of COVID-19 in non-hospitalized pregnant women. Higher antithrombotics use post-COVID-19 suggests prophylactic treatment in this population.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Reduction in Spontaneous and Iatrogenic Preterm Births in Twin Pregnancies During COVID-19 Lockdown in Melbourne, Australia: A Multicenter Cohort Study 94%
- Pregnancy during COVID-19: social contact patterns and vaccine coverage of pregnant women from CoMix in 19 European countries 92%
- Social inequalities in pregnancy metabolic profile: findings from the multi-ethnic Born in Bradford cohort study 91%
Similar papers in this journal
- Maternal pre-pregnancy body mass index and risk of preterm birth: a collaboration using large routine health datasets 94%
- Assessing the impact of maternal blood pressure during pregnancy on perinatal health: A wide-angled Mendelian randomization study 92%
- Evidence for treatment with estradiol for women with SARS-CoV-2 infection 91%
Similar papers in this journal
- Effect of caesarean birth on perinatal mortality for singleton breech presentation in spontaneous preterm labour – a target trial emulation using Scottish health record data 93%
- Protocol for a sequential, prospective meta-analysis to describe coronavirus disease 2019 (COVID-19) in the pregnancy and postpartum periods 93%
- How do perceptions of Covid-19 risk impact pregnancy-related health decisions? A convergent parallel mixed-methods study protocol 93%
Similar papers in this journal
- Landscape Analysis of Pregnancy Exposure Registries in Low- and Middle-Income Countries: a Scoping Review 93%
- Birhan Maternal and Child Health cohort: a study protocol 92%
- Safety of RSV Vaccine among Pregnant Individuals: A Real-World Pharmacovigilance Study Using Vaccine Adverse Event Reporting System 92%
Similar papers in this journal
- SARS-CoV-2 (COVID-19) infection in pregnant women: characterization of symptoms and syndromes predictive of disease and severity through real-time, remote participatory epidemiology 95%
- Widely accessible prognostication using medical history for fetal growth restriction and small for gestational age in nationwide insured women 94%
- Synergistic effects of cardiovascular health and social isolation on adverse pregnancy outcomes 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.